Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial
- DOI
- 10.1016/s2352-3026(26)00249-8
- Published
- 2026-11
- Container
- The Lancet Haematology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-3026-26-00249-8,
title = {Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial},
author = {Jeffrey I Zwicker and Aaron P Kithcart and Justin Kaplan and Poulabi Banerjee and Keshini Vyas and Dan Chalothorn and José G Raya and Siyu Li and Laura E Fredenburgh and Mihaela Mocan and Rosen Razboynikov and Lori G Morton and David E Gutstein and Kathryn M Musgrave and Gregory Piazza and Mihaela Mocan and Rosen Razboynikov and Lucian Calmac and Jeffrey I Zwicker and Gregory Piazza and Gerald Soff and Hannah Lee and Ilana Kopolovic and Alejandro Lazo-Langner and Rashid Kazmi and Ariella Tvito and Amichay Meirovitz},
year = {2026},
journal = {The Lancet Haematology},
doi = {10.1016/s2352-3026(26)00249-8},
url = {https://doi.org/10.1016/s2352-3026(26)00249-8}
}RIS
TY - JOUR TI - Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial AU - Jeffrey I Zwicker AU - Aaron P Kithcart AU - Justin Kaplan AU - Poulabi Banerjee AU - Keshini Vyas AU - Dan Chalothorn AU - José G Raya AU - Siyu Li AU - Laura E Fredenburgh AU - Mihaela Mocan AU - Rosen Razboynikov AU - Lori G Morton AU - David E Gutstein AU - Kathryn M Musgrave AU - Gregory Piazza AU - Mihaela Mocan AU - Rosen Razboynikov AU - Lucian Calmac AU - Jeffrey I Zwicker AU - Gregory Piazza AU - Gerald Soff AU - Hannah Lee AU - Ilana Kopolovic AU - Alejandro Lazo-Langner AU - Rashid Kazmi AU - Ariella Tvito AU - Amichay Meirovitz PY - 2026 JO - The Lancet Haematology DO - 10.1016/s2352-3026(26)00249-8 UR - https://doi.org/10.1016/s2352-3026(26)00249-8 ER -
APA
Zwicker, J. I., Kithcart, A. P., Kaplan, J., Banerjee, P., Vyas, K., Chalothorn, D., Raya, J. G., Li, S., Fredenburgh, L. E., Mocan, M., Razboynikov, R., Morton, L. G., Gutstein, D. E., Musgrave, K. M., Piazza, G., Mocan, M., Razboynikov, R., Calmac, L., Zwicker, J. I., Piazza, G., Soff, G., Lee, H., Kopolovic, I., Lazo-Langner, A., Kazmi, R., Tvito, A., & Meirovitz, A. (2026). Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(26)00249-8
Source records
- crossref · retrieved 2026-11-09T04:08:08.139Z